NEW YORK, July 14 Delcath Systems, Inc. (Nasdaq: DCTH) today announced that it will release financial results for the second quarter ended June 30, 2009 on Monday, July 27, 2009 after the market close. In addition, Eamonn Hobbs, the Company's new President & CEO will host a conference call and webcast on Monday, July 27, 2009 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's recent progress. The dial-in number for the conference call is 877-941-0844 for domestic participants and 480-629-9645 for international participants.
Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO)
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4117854#. To access the live webcast of the call, go to Delcath's website at www.delcath.com. An archived webcast will also be available at www.delcath.com.
Advertisement
About Delcath Systems
Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer. The Company's technology, known as Percutaneous Hepatic Perfusion (PHP), allows physicians to deliver significantly higher doses of anti-cancer drugs to the site of disease without exposing the patient's entire body to those same potent levels of drug. Initial clinical results from studies treating cancer in the liver confirm that delivering more drug to the tumor site, and less to the other regions of the body, enhances tumor shrinkage with improved quality of life over systemic cancer therapies. PHP is currently undergoing testing in Phase III and Phase II clinical trials for a variety of cancers of the liver. More information is available at http://www.delcath.com.
SOURCE Delcath Systems, Inc.
